Top three applications of Nutraceuticals

The Indian nutraceutical market is witnessing significant growth & hence nutraceutical companies will play a huge role in combating health issues.

Cipla's consolidated net profit increased 6.5% in the third quarter to Rs. 807 crore

Cipla, a Rs. 21,600 crore plus pharma major, reported single-digit revenue and profit growth in the third quarter ended December 2022. Its consolidated revenues increased by 6% to Rs. 5,810 crore, up from Rs. 5,479 crore in the same period last...

Sirnaomics to accelerate the clinical development of STP705 for the treatment of non-melanoma skin malignancies

Sirnaomics Ltd., a leading biopharmaceutical firm in the research and development of RNAi therapies, reported that STP705 is moving forward in clinical trials for the treatment of two non-melanoma skin cancers:..

US FDA approves Ellipses Pharma's IND application for EP0042 for treatment of acute myeloid leukaemia

Ellipses Pharma (Ellipses), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, announced that the US Food and Drug Administration (FDA) has...

TDMA to improve its performance to strengthen pharma MSME sector in Telangana

The overall performance of the Telangana Drug Manufacturers Association (TDMA), which is the state affiliate of the Indian Drug Manufacturers’ Association (IDMA), will be improved to strengthen the activities connected with the pharma MSME sector...

Pharmaceutical Industry receives a budget boost as the FM announces a programme to promote R&D

Finance Minister Nirmala Sitharaman announced on Wednesday a new programme to promote pharmaceutical research and innovation through various centres of excellence. "We will also encourage industry to invest in R&D," ...

Ashirvad Hospital Varanasi redefines healthcare in developing cities through hospital architecture

Improving hospital architecture in India has the potential to significantly improve healthcare accessibility. According to Alpana Gupta, partner at Vijay Gupta Architects, extensive studies conducted by healthcare professionals and healthcare...

Domestic pharmaceutical market is expected to reach $130 billion by 2030

The domestic pharmaceutical market in India is projected to reach USD 130 billion by 2030, and the pharma sector has maintained its growing momentum after the pandemic. In FY21, the nation's pharmaceutical exports saw a strong growth of 24%,...

Alkem launches novel antibiotic for MDR infections

Alkem (Intenza, critical care division) announced the launch of its novel anti-infective in India under the brand name Zidavi. The newly launched antibiotic for multiple drug resistance (MDR) infections is in line with the company’s endeavour to...

Slovenian firm Krka eyeing promoter stake in Unichem

Slovenian pharmaceutical firm Krka, d. d., Novo mesto is in discussions to acquire the promoter’s stake in Mumbai-based Unichem Laboratories, said two people aware of the development.

© 2025 India Pharma Outlook. All Rights Reserved.